CHICAGO, IL, 29 Nov, 2024: Cercare Medical invites RSNA attendees to an exclusive evening event
on December 2, 2024, at the Marriott Hotel in Chicago. This premier gathering will highlight groundbreaking advancements in stroke and neuro-oncology imaging, with a keynote presentation by Dr. Alexandre Bani-Sadr, MD, PhD, whose recent study was featured on the front page of Stroke journal.
Dr. Bani-Sadr’s research demonstrates the transformative role of Oxygen Extraction Fraction (OEF) mapping in predicting brain tissue recovery post-thrombectomy, underscoring the power of
Cercare Medical’s advanced imaging biomarkers in stroke care.
“We’re thrilled to have Dr. Bani-Sadr share insights from his study at our event,” said Randy Rohmer, U.S. Commercial Lead at Cercare Medical. “This is a unique opportunity to explore how our technology is pushing the boundaries of precision medicine.”
Event Details:
Join us to learn more about the latest innovations in metabolic perfusion imaging and network with
leading professionals in the field.
Limited seating is available. Reserve your spot today!
Cercare Medical’s advanced imaging tools, including Capillary Transit Time Heterogeneity (CTH) and OEF mapping, allow for unparalleled precision in perfusion imaging. These biomarkers enable clinicians to gain a clearer view of cerebral oxygenation and tissue health in stroke patients, which is crucial for determining the most effective course of action. By integrating these technologies into stroke treatment protocols, Cercare Medical supports clinicians worldwide in delivering faster, more accurate, and highly personalized care.
